Biotech | October 30, 2023
EnginZyme produces key mRNA vaccine ingredient using biocatalysis
2023 Nobel laureates discovered how pseudouridine could make mRNA suitable for vaccines
2023 Nobel laureates discovered how pseudouridine could make mRNA suitable for vaccines
Prateek has more than 23 years of rich experience in Human Resource
India confronts alarming rates of eye disorders, propelling the urgency of eyecare awareness
The companies will work with investigators to share the results with the scientific community
Opinion granted based on positive disease-free survival results from the Phase 3 KEYNOTE-091 trial
This advanced technology is specifically tailored for individuals with high power prescriptions, aiming to free the 18-35 age group from the reliance on eyeglasses
The facility has a potential for capacity expansion up to 2 billion tablets/capsules per year
KEYTRUDA is the first immunotherapy approved in the EU for the first-line treatment of this patient population
Honeywell Solstice Air is a hydrofluoroolefin (HFO) propellant in clinical development today for pMDIs
The survey findings for Delhi-NCR revealed that speech sound disorders exhibit higher prevalence rates in the 6-12 years age group
Subscribe To Our Newsletter & Stay Updated
